Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/03/2023 | 17.76% | UBS | → $237 | Initiates Coverage On | → Buy |
08/03/2023 | 14.29% | Morgan Stanley | $200 → $230 | Maintains | Overweight |
08/03/2023 | 7.33% | Barclays | $198 → $216 | Maintains | Equal-Weight |
08/03/2023 | 9.32% | Raymond James | $200 → $220 | Maintains | Outperform |
07/18/2023 | -1.61% | Barclays | → $198 | Initiates Coverage On | → Equal-Weight |
06/30/2023 | 1.86% | Citigroup | → $205 | Initiates Coverage On | → Buy |
05/04/2023 | -5.59% | Credit Suisse | $195 → $190 | Maintains | Outperform |
04/19/2023 | 1.86% | Stifel | $215 → $205 | Maintains | Buy |
04/19/2023 | 1.86% | JP Morgan | $225 → $205 | Maintains | Overweight |
04/19/2023 | -0.62% | Morgan Stanley | $228 → $200 | Maintains | Overweight |
04/19/2023 | -0.62% | B of A Securities | $240 → $200 | Downgrades | Buy → Neutral |
04/19/2023 | -3.11% | Credit Suisse | $230 → $195 | Maintains | Outperform |
02/09/2023 | 13.29% | Morgan Stanley | $217 → $228 | Maintains | Overweight |
02/09/2023 | 14.29% | Credit Suisse | $220 → $230 | Maintains | Outperform |
02/09/2023 | 14.29% | Citigroup | $210 → $230 | Maintains | Buy |
02/09/2023 | 9.32% | Raymond James | $200 → $220 | Maintains | Outperform |
01/18/2023 | 7.83% | Morgan Stanley | $210 → $217 | Maintains | Overweight |
01/18/2023 | 9.32% | Credit Suisse | $202 → $220 | Maintains | Outperform |
12/20/2022 | 11.8% | JP Morgan | $215 → $225 | Maintains | Overweight |
11/03/2022 | 4.35% | Citigroup | $220 → $210 | Maintains | Buy |
11/03/2022 | 4.35% | Morgan Stanley | $200 → $210 | Maintains | Overweight |
11/03/2022 | -0.62% | Raymond James | $220 → $200 | Maintains | Outperform |
10/17/2022 | -0.62% | Morgan Stanley | $227 → $200 | Maintains | Overweight |
08/17/2022 | 0.37% | Credit Suisse | → $202 | Initiates Coverage On | → Outperform |
07/14/2022 | — | JP Morgan | Upgrades | Neutral → Overweight | |
06/28/2022 | 4.35% | Evercore ISI Group | $250 → $210 | Maintains | Outperform |
05/05/2022 | 12.8% | Morgan Stanley | $214 → $227 | Maintains | Overweight |
04/14/2022 | 4.35% | Stifel | $200 → $210 | Upgrades | Hold → Buy |
03/31/2022 | 6.34% | Morgan Stanley | $201 → $214 | Upgrades | Equal-Weight → Overweight |
02/10/2022 | -0.12% | Morgan Stanley | $200 → $201 | Maintains | Equal-Weight |
02/02/2022 | 9.32% | Raymond James | $210 → $220 | Maintains | Outperform |
11/04/2021 | -0.62% | Morgan Stanley | $196 → $200 | Maintains | Equal-Weight |
11/04/2021 | 4.35% | Raymond James | $205 → $210 | Maintains | Outperform |
10/06/2021 | -2.61% | Morgan Stanley | $208 → $196 | Downgrades | Overweight → Equal-Weight |
09/29/2021 | -0.62% | JP Morgan | $195 → $200 | Upgrades | Underweight → Neutral |
08/05/2021 | 3.35% | Morgan Stanley | $190 → $208 | Maintains | Overweight |
08/05/2021 | 4.35% | Credit Suisse | $200 → $210 | Maintains | Outperform |
05/06/2021 | -0.62% | Credit Suisse | $175 → $200 | Maintains | Outperform |
04/16/2021 | -5.59% | Morgan Stanley | $188 → $190 | Maintains | Overweight |
04/08/2021 | -6.58% | Morgan Stanley | $164 → $188 | Maintains | Overweight |
02/11/2021 | -13.04% | Citigroup | $145 → $175 | Maintains | Buy |
02/11/2021 | -13.04% | Credit Suisse | $150 → $175 | Maintains | Outperform |
02/04/2021 | -18.51% | Morgan Stanley | → $164 | Upgrades | Equal-Weight → Overweight |
11/03/2020 | -28.45% | Morgan Stanley | $136 → $144 | Maintains | Equal-Weight |
10/13/2020 | -32.42% | Morgan Stanley | $124 → $136 | Maintains | Equal-Weight |
08/12/2020 | -30.43% | Citigroup | → $140 | Initiates Coverage On | → Buy |
08/06/2020 | -38.39% | Morgan Stanley | $120 → $124 | Maintains | Equal-Weight |
06/29/2020 | -30.43% | Raymond James | → $140 | Upgrades | Market Perform → Outperform |
06/09/2020 | -40.37% | Morgan Stanley | → $120 | Upgrades | Underweight → Equal-Weight |
06/09/2020 | -42.86% | JP Morgan | → $115 | Downgrades | Neutral → Underweight |
05/07/2020 | -40.37% | CFRA | $139 → $120 | Maintains | Hold |
05/07/2020 | -54.78% | Morgan Stanley | $80 → $91 | Maintains | Underweight |
04/17/2020 | -36.89% | Credit Suisse | $155 → $127 | Maintains | Outperform |
04/17/2020 | -60.25% | Morgan Stanley | $78 → $80 | Maintains | Underweight |
03/25/2020 | -61.24% | Morgan Stanley | $123 → $78 | Maintains | Underweight |
03/23/2020 | -37.89% | B of A Securities | $150 → $125 | Reiterates | → Buy |
02/28/2020 | -40.37% | JP Morgan | → $120 | Upgrades | Underweight → Neutral |
01/17/2020 | -38.39% | Morgan Stanley | $126 → $124 | Downgrades | Equal-Weight → Underweight |
11/01/2019 | -37.39% | Morgan Stanley | $107 → $126 | Maintains | Equal-Weight |
08/05/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
07/30/2019 | — | B of A Securities | Initiates Coverage On | → Buy | |
07/26/2019 | -47.33% | Morgan Stanley | $97 → $106 | Maintains | Equal-Weight |
06/11/2019 | -43.85% | Deutsche Bank | → $113 | Reinstates | → Buy |
06/06/2019 | -40.37% | Evercore ISI Group | → $120 | Initiates Coverage On | → Outperform |
04/26/2019 | — | Northcoast Research | Downgrades | Buy → Neutral | |
04/17/2019 | -47.83% | Stifel | $100 → $105 | Downgrades | Buy → Hold |
04/11/2019 | -41.86% | Credit Suisse | → $117 | Initiates Coverage On | → Outperform |
What is the target price for CDW (CDW)?
The latest price target for CDW (NASDAQ: CDW) was reported by UBS on October 3, 2023. The analyst firm set a price target for $237.00 expecting CDW to rise to within 12 months (a possible 17.76% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CDW (CDW)?
The latest analyst rating for CDW (NASDAQ: CDW) was provided by UBS, and CDW initiated their buy rating.
When is the next analyst rating going to be posted or updated for CDW (CDW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CDW, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CDW was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
Is the Analyst Rating CDW (CDW) correct?
While ratings are subjective and will change, the latest CDW (CDW) rating was a initiated with a price target of $0.00 to $237.00. The current price CDW (CDW) is trading at is $201.25, which is within the analyst's predicted range.